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Achieving Racial and Ethnic
Fairness in Drug Courts
Douglas B. Marlowe

I

n June 2010, the Board of Directors of the National
Association of Drug Court Professionals (NADCP) passed a
unanimous resolution directing drug courts to examine
whether unfair disparities exist in their programs for racial or
ethnic minority participants, and if so, to take reasonable corrective measures to eliminate such disparities.1 The resolution
places an affirmative obligation on drug courts to continuously
monitor whether minority participants have equal access to
the programs, receive substantially equivalent services in the
programs, and successfully complete the programs at equivalent rates to non-minorities.2 The resolution further directs
drug courts to adopt evidence-based assessment tools and clinical interventions that are scientifically proven to be valid and
effective for minority participants, and to instruct staff members to attend up-to-date training events on the provision of
culturally sensitive and culturally proficient services.3
As a professional membership and training organization,
the NADCP has no enforcement authority over drug courts,
which are typically governed by the administrative office of the
courts, Supreme Court, or attorney disciplinary board in each
state or territory. However, the NADCP is widely regarded as a
leading national organization on best practices and evidencebased practices in drug courts, and its word carries considerable weight in the field. When the NADCP speaks definitively
on an issue such as this, practitioners, policymakers, and funding agencies may come to view the recommendations as
indicative of appropriate standards of practice for drug courts.
This article provides a backdrop to the NADCP Board

Footnotes
1. NAT’L ASS’N DRUG CT. PROF., RESOLUTION OF THE BOARD OF
DIRECTORS ON THE EQUIVALENT TREATMENT OF RACIAL AND ETHNIC
MINORITY PARTICIPANTS IN DRUG COURTS, available at
http://www.nadcp.org/sites/default/files/nadcp/NADCP%20Board
%20Resolution%20-%20The%20Equivalent%20Treatment%20
of%20Racial%20and%20Ethnic%20Minority%20Participants%20
in%20Drug%20Courts%2006-01-10.pdf [hereafter NADCP
MINORITY RESOLUTION].
2. Id. at 2.
3. Id. at 2-3.
4. See generally Donald P. Green & Daniel Winik, Using Random
Judge Assignments to Estimate the Effects of Incarceration and
Probation on Recidivism Among Drug Offenders, 48 CRIMINOLOGY
357, 381 (2010) (concluding incarceration had little effect on
likelihood of re-arrest for drug offenders); Cassia Spohn & David
Holleran, The Effect of Imprisonment on Recidivism Rates of Felony
Offenders: A Focus on Drug Offenders, 40 CRIMINOLOGY 329, 346
(2002) (finding incarcerated drug offenders were more likely to
recidivate than those sentenced to probation); Jonathan P.
Caulkens & Sara Chandler, Long-Run Trends in Incarceration in the
United States, 52 CRIME & DELINQ. 619, 630 (2006) (finding incarceration does not dramatically reduce drug use and is not costeffective).
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Resolution and reviews what is currently known, and not yet
known, about racial-and-ethnic-minority impacts in drug
courts. After briefly describing what drug courts are and why
they came to be, research is presented on minority access to drug
courts, the services received by minorities in drug courts, and
the outcomes produced. Virtually all of the empirical research to
date has focused on African-American participants and those of
Hispanic and Latino/Latina ethnicity. This is largely due to the
fact that these groups have been represented in sufficient numbers in many studies for evaluators to conduct separate analyses
on their behalf. Additional efforts are needed to examine drugcourt impacts on other racial and ethnic minority groups.
I. DRUG COURTS

The “War on Drugs” of the 1980s emphasized incarceration
as a principal response to drug-related crime. It is now evident
that this policy had a minimal effect on criminal recidivism,4
was prohibitively costly,5 and disproportionately harmed racial
and ethnic minorities and the poor.6 Nearly one out of every
100 adult citizens is now behind bars in the United States,7 and
the rates are substantially higher for minorities: approximately
one out of every 15 African-American adult males and one out
of every 36 Hispanic adult males are behind bars.8
Drug courts emerged as one alternative to the War on Drugs
that emphasizes community-based treatment and rehabilitation in lieu of prosecution or incarceration.9 The drug-court
judge leads a multidisciplinary team of professionals that commonly includes representatives from the prosecutor’s office,

5. See PEW CTR. ON STATES, HIGH COST, LOW RETURN: DESPITE THE
MASSIVE INCREASE IN THE SIZE AND COST OF AMERICA’S CORRECTIONAL
SYSTEM, THE NATIONAL RECIDIVISM RATE REMAINS STUBBORNLY HIGH,
available at http://www.pewstates.org/uploadedimages/PCS_
Assets/Graphics/PSPP_infographic.png [hereinafter HIGH COST,
LOW RETURN] (finding 1 in 14 state general fund dollars spent on
corrections, totaling $52 billion in 2011).
6. See generally E. L. Jensen et al., Social Consequences of the War on
Drugs: The Legacy of Failed Policy, 15 CRIM. JUST. POL’Y REV. 100
(2004) (reviewing harmful impacts of War on Drugs on minorities and minority communities); Martin Y. Iguchi et al., How
Criminal System Racial Disparities May Translate into Health
Disparities, 16 J. HEALTH CARE FOR POOR & UNDERSERVED 48 (2005)
(linking disproportionate confinement of minorities for drug
offenses to severe health and mental-health impairments).
7. HIGH COST, LOW RETURN, supra note 5, at 1 (finding 1 in 104
American adults was behind bars in 2011); PEW CTR. ON STATES,
ONE IN 100: BEHIND BARS IN AMERICA 2008 (2008) [hereinafter ONE
IN 100] (finding 1 in 100 American adults behind bars in 2008).
8. ONE IN 100, supra note 7, at 6.
9. See generally NAT’L ASS’N DRUG CT. PROF., DEFINING DRUG COURTS:
THE KEY COMPONENTS (1997) (describing the core ingredients of
and services delivered in drug courts).

defense bar, treatment agencies, case-management agency, and
probation department. The team members meet frequently to
review participants’ progress and offer recommendations to the
judge about suitable consequences to impose. The consequences may include desired rewards such as verbal praise,
reduced supervision requirements, or token gifts; punitive
sanctions such as verbal reprimands, community service, or
brief intervals of jail detention; or adjustments to participants’
treatment regimens. The consequences are typically administered during regularly scheduled status hearings in which the
judge discusses the matter with the participant in open court.
In pre-adjudication drug courts, the ultimate incentive is to
have the criminal charge(s) dropped or withdrawn, and in
post-adjudication drug courts the ultimate incentive is to avoid
incarceration or reduce the length or conditions of probation.10
Several scientific meta-analyses11 and a large-scale national
study12 have concluded that drug courts significantly reduce
crime and return an average of more than $2 in direct financial
benefits to the criminal justice system for every $1 invested.13
The success of adult drug courts has spawned a wide variety of
other types of problem-solving courts, including juvenile drug
courts, family drug courts, driving-while-impaired (DWI)
courts, mental-health courts, and prisoner-reentry courts.14
Although research has not advanced nearly as much for these

newer programs as it has for
[C]ontroversy has
adult drug courts, evidence is
surrounded the
promising to support the
effectiveness of several of the
question of what
newer models.15
impacts, if any,
Almost from their incepdrug courts might
tion, controversy has surrounded the question of what have on preexisting
impacts, if any, drug courts
racial or ethnic
might have on preexisting
disparities in
racial or ethnic disparities in
the criminal
the criminal justice system.
Researchers and commentajustice system.
tors have variably concluded
that drug courts reduce disparities,16 exacerbate disparities,17
or that insufficient evidence exists to know what effects they
may have.18 This confusion stems from at least two sources.
First, many researchers have sorely neglected the issue. Most
evaluations have not reported outcomes separately by race or
ethnicity; and among those that have, few evaluators performed the type of detailed inquiry and analyses that are
required to validly interpret the findings. For example, as will
be discussed,19 when racial or ethnic differences have been
detected, evaluators rarely sought to determine whether those

10. See, e.g., David S. Festinger et al., Expungement of Arrest Records in
Drug Court: Do Clients Know What They’re Missing?, 5 DRUG CT.
REV. 1, 5 (2005) (reviewing the legal benefits of successful graduation from drug court).
11. See generally Ojmarrh Mitchell et al., Assessing the Effectiveness of
Drug Courts on Recidivism: A Meta-Analytic Review of Traditional
and Non-Traditional Drug Courts, 40 J. CRIM. JUST. 60, 66 (2012)
(concluding drug courts reduced crime by an average of 12%);
David B. Wilson et al., A Systematic Review of Drug Court Effects on
Recidivism, 2 J. EXPERIMENTAL CRIMINOLOGY 459, 479 (2006) (concluding drug courts reduced crime an average of 14-26%);
Christopher T. Lowenkamp et al., Are Drug Courts Effective: A
Meta-Analytic Review, 15 J. COMMUNITY CORRECTIONS 5, 8 (2005)
(concluding drug courts reduced crime an average of 7.5%); JEFF
LATIMER ET AL., CANADA DEPT. JUSTICE, A META-ANALYTIC
EXAMINATION OF DRUG TREATMENT COURTS: DO THEY REDUCE
RECIDIVISM? 9 (2006) (concluding drug courts reduced crime an
average of 14%); Deborah Koetzle-Shaffer, Looking Inside the Black
Box of Drug Courts: A Meta-Analytic Review, 28 JUST. Q. 493, 508
(2010) (concluding drug courts reduced crime an average of 9%);
STEVE AOS ET AL., WASHINGTON ST. INST. PUB. POL’Y, EVIDENCE-BASED
ADULT CORRECTIONS PROGRAMS: WHAT WORKS AND WHAT DOES NOT
at 9, Table 4 (2006) (concluding drug courts reduced crime an
average of 8%); U.S. GOV’T ACCOUNTABILITY OFF., ADULT DRUG
COURTS: STUDIES SHOW COURTS REDUCE RECIDIVISM, BUT DOJ COULD
ENHANCE FUTURE PERFORMANCE MEASURE REVISION EFFORTS 19
(2011) (concluding drug courts significantly reduced crime by 6
to 26 percentage points).
12. See generally Michael Rempel et al., The Impact of Adult Drug
Courts on Crime and Incarceration: Findings From a Multi-Site
Quasi-Experimental Design, J. EXPERIMENTAL CRIMINOLOGY, available at DOI: 10.1007/s11292-012-9143-2 (finding probability of
re-offending reduced by almost one quarter in national study of 23
adult drug courts).
13. See generally AVINASH S. BHATI ET AL., URBAN INST., TO TREAT OR NOT
TO TREAT: EVIDENCE ON THE PROSPECTS OF EXPANDING TREATMENT TO

DRUG-INVOLVED OFFENDERS 56 (2008) (finding drug courts
returned an average of $2.21 for every $1 invested, for net benefit
to society of $624 million in 2006).
14. See generally WEST HUDDLESTON & DOUGLAS B. MARLOWE, NAT’L
DRUG CT. INST., PAINTING THE CURRENT PICTURE: A NATIONAL REPORT
ON DRUG COURTS AND OTHER PROBLEM-SOLVING COURT PROGRAMS IN
THE UNITED STATES (2011) (defining and tallying the number of
various types of problem-solving courts in the U.S. and internationally).
15. See generally Douglas B. Marlowe, The Verdict on Drug Courts and
Other Problem-Solving Courts, 2 CHAPMAN J. CRIM. JUST. 53 (2011)
(reviewing research on various types of problem-solving courts).
16. See Michael Wright, Reversing the Prison Landscape: The Role of
Drug Courts in Reducing Minority Incarceration, 8 RUTGERS RACE &
L. REV. 79, 81 (2006) (stating drug courts have the “potential, not
only to reduce minority incarceration, but also to heal minority
communities”); MARC MAUER, SENTENCING PROJ., THE CHANGING
RACIAL DYNAMICS OF THE WAR ON DRUGS 2, 14 (2009) (concluding
drug courts, especially those in urban communities, are likely to
be disproportionately benefiting African-Americans by diverting
them from prison).
17. See NAT’L ASSOC. CRIM. DEFENSE LAWYERS, AMERICA’S PROBLEMSOLVING COURTS: THE CRIMINAL COSTS OF TREATMENT AND THE CASE
FOR REFORM 42 (2009) [hereafter NACDL REPORT] (concluding
racial prejudice pervades the criminal justice system, and drug
courts are no exception); JUST. POL’Y INST., ADDICTED TO COURTS:
HOW A GROWING DEPENDENCE ON DRUG COURTS IMPACTS PEOPLE AND
COMMUNITIES 23 (2011) (concluding people of color are more
likely to be kicked out of drug courts); Michael M. O’Hear,
Rethinking Drug Courts: Restorative Justice as a Response to Racial
Injustice, 20 STAN. L. & POL’Y REV. 463, 479-480 (2009) (concluding drug courts exacerbate racial disparities).
18. See Robert V. Wolf, Race, Bias, and Problem-Solving Courts, 21 NAT’L
BLACK L. J. 27, 44 (2009) (noting “dearth of data” on race and drug
courts; rather than answers, researchers have only questions).
19. See infra notes 44-50 and accompanying text.
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differences might have been
influenced by extraneous factors, such as participants’
socioeconomic status (SES) or
drug of choice—which may
have been coincidentally correlated with race and truly
responsible for the differential
effects.
Second, some advocacy
groups have seized upon the
possibility of disparate racial
impacts as a wedge issue to
wield against drug courts and
in favor of their alternative policy proposals, such as drug decriminalization20 or a restorativejustice philosophy.21 Putting aside for the moment the correctness of their alternative proposals, some of these advocates
have marshaled weak and contradictory “evidence” against
drug courts, including unverifiable anecdotes, biased correlations, and mischaracterizations of what researchers have
reported in their publications. Given the potential for this hotbutton issue to inflame passions on all sides of the conversation, it is imperative for serious-minded and duly trained scientists to carefully examine what is confidently known about
minority impacts in drug courts and what matters require further exploration and deliberation.

[I]t is imperative
for seriousminded and duly
trained scientists
to carefully
examine what is
confidently known
about minority
impacts in drug
courts . . . .

II.

MINORITY ACCESS TO DRUG COURTS

Drug courts have been alternately accused of unfairly
excluding minority citizens from participation in the programs22 and over-targeting minorities—thus drawing them
deeper into the criminal justice system—a phenomenon
known as net-widening.23 Virtually all of these assertions have
been anecdotal24 because representative data are sparse and
very difficult to come by.25
A 2008 survey of all state and territorial drug-court coordinators in the U.S. estimated that African-Americans comprised
approximately 21% of drug-court participants nationally, and
Hispanic and Latino/Latina citizens comprised approximately
10% of drug-court participants (see Table 1).26 There was wide
variability around these averages, with some drug courts
reporting less than 1% minority participants in their programs
and others reporting more than 95% minorities.27
As points of reference, these figures were contrasted against
those derived from national studies of arrestees, probationers
and parolees, prison inmates, and jail inmates.28
Representation of African-Americans was estimated to be
approximately 7 percentage points lower in drug courts than in
the arrestee and probation-and-parole populations (21% vs.
28% and 28%), and approximately 20 percentage points lower
than in jails and prisons (21% vs. 39% and 44%).
Representation of Hispanic and Latino/Latina citizens was estimated to be nearly equivalent to the probation-and-parole population (10% vs. 13%), and approximately 6 to 10 percentage

TABLE 1: MINORITY REPRESENTATION IN DRUG COURTS COMPARED WITH OTHER CRIMINAL JUSTICE PROGRAMS IN 2008

African-American

% Difference in
Drug Courts

Hispanic and
Latino or Latina

% Difference in
Drug Courts

Drug Courts

21%

10%

Arrestees

28%

-7%

Not Reported

Probationers & Parolees

28%

-7%

13%

-3%

Jail Inmates

39%

-18%

16%

-6%

Prison Inmates

44%

-23%

20%

-10%

Source: West Huddleston & Douglas B. Marlowe, Painting the Current Picture: A National Report on Drug Courts and Other Problem-Solving Court Programs
in the United States, at 30, Table 6 (Nat’l Drug Ct. Inst., 2011). Adapted with permission.

20. See NACDL REPORT, supra note 17, at 20-21 (advocating for the
decriminalization of all controlled substances in lieu of supporting drug courts); DRUG POL’Y ALLIANCE, DRUG COURTS ARE NOT THE
ANSWER: TOWARD A HEALTH-CENTERED APPROACH TO DRUG USE 19
(2011) (advocating for the removal of all criminal penalties for
drug use in lieu of providing diversion opportunities within the
criminal justice system, as in drug courts); JUST. POL’Y INST., supra
note 17, at 26 (advocating for voluntary community-based treatment in lieu of drug courts).
21. See O’Hear, supra note 17, at 125-136 (advocating for a restorative
justice model in lieu of drug courts).
22. See, e.g., NACDL REPORT, supra note 17, at 42-43 (asserting drug
courts were developed for middle-class teens and minorities are
rarely accepted); JUST. POL’Y INST., supra note 17, at 21 (asserting
people of color are more likely to have prior felony convictions
making them ineligible for drug court).
23. See, e.g., DRUG POL’Y ALLIANCE, supra note 20, at 8 (asserting drug
courts may increase the number of people of color brought into
the criminal justice system).
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24. See, e.g., NACDL REPORT, supra note 17, at 42-43 (quoting one
public defender’s anecdotal experiences in one Utah drug court as
evidence that drug courts discriminate).
25. Id. at 42 (acknowledging the extent of the problem cannot be adequately analyzed because relevant data “simply does not exist”);
Wolf, supra note 18, at 30 (noting “virtually nothing” written
about specialized courts has addressed the issues of race and bias).
26. HUDDLESTON & MARLOWE, supra note 14, at 28-29. These figures
represent best estimates because the data were collected at the
state level and the quality of statewide statistics on minority
impacts was variable.
27. Id. at 28-29, Tables 4, 5.
28. The sources for the comparison data were: FEDERAL BUREAU OF
INVESTIGATION, FBI CRIME REPORTING DATA, 2008; BUREAU OF
JUSTICE STATISTICS, JAIL INMATES AT MIDYEAR 2007 (NCJ #221945);
BUREAU OF JUSTICE STATISTICS, PROBATION AND PAROLE IN THE UNITED
STATES, 2008 (NCJ #228230); BUREAU OF JUSTICE STATISTICS,
PRISONERS IN 2008 (NCJ #228417).

points lower than in jails and prisons (10% vs. 16% and 20%).
Taken together, these national statistics suggest that drug
courts may be under serving racial and ethnic minority citizens, but the magnitude of the problem appears to be far
smaller than that asserted by some critics. Based on these findings, a reasonable benchmark for improvement in drug courts
would be to increase minority representation by approximately
7 percentage points so as to be equivalent with the arrestee and
probationer populations.
A much greater concern relates to the disproportionate confinement of minorities, particularly African-Americans, in jails
and prisons.29 As can be seen from the above table, AfricanAmericans were considerably less likely to be on community
supervision than in jail or prison (28% vs. 39% or 44%). In
contrast, Caucasians were more likely to be on community
supervision than in jail or prison (56% vs. 43% or 34%).30
Fortunately, a national study recently found that the number of African-Americans in state prisons for drug-related
crimes has declined by nearly 22% since the advent of drug
courts and similar treatment-oriented diversion programs.31
After ruling out several alternative explanations for this development, such as changing drug-use rates among minorities,
the report credited the rapid expansion of drug courts as one
likely contributor to the precipitous decline.32 Drug courts
offer an evidence-based alternative to incarceration that
defense attorneys can propose and judges and prosecutors can
take into consideration during the plea bargaining and sentencing processes. If drug courts were to disappear, minority
representation in jails and prisons would be expected to rise
as opposed to decline,33 contrary to what some policy advocates have asserted.34
Nevertheless, drug courts cannot and do not accept dispro-

portionate minority represen[D]rug courts
tation in their programs, no
matter how small the magni- should ensure that
tude. Therefore, drug courts their eligibility and
have set for themselves an
exclusion criteria
obligation to make all reasonare objective and
able efforts to bring minority
representation in line with the
race-neutral both
applicable arrestee population in intent and effect.
in their respective jurisdictions.35 Examples of reasonable steps to be taken include ensuring that all assessment
tools used for determining eligibility are equally valid and predictive for minorities as for non-minorities.36 In addition, drug
courts should ensure that their eligibility and exclusion criteria are objective and race-neutral both in intent and effect. If an
eligibility requirement has the unintended consequence of differentially restricting access for minorities, then extra assurances should be required that it is a necessary prerequisite for
the program to achieve effective outcomes and protect public
safety.37 Where less restrictive adjustments can be made to a
drug court’s eligibility criteria to increase minority representation without jeopardizing safety or efficacy, it should be
incumbent upon the program to implement such adjustments.

29. See supra notes 6-8 and accompanying text.
30. HUDDLESTON & MARLOWE, supra note 14, at 30, Table6.
31. See generally MAUER, supra note 16.
32. Id. at 14 (concluding “it is likely that at least in some jurisdictions
there are people charged with a drug offense who are diverted
from a prison term due to drug court programming”).
33. Cf. Wolf, supra note 18, at 46-47 (noting studies show minorities
express more support than Caucasians for alternatives to incarceration, such as problem-solving courts).
34. See supra note 23 and infra notes 69-72 and accompanying text.
35. See NADCP MINORITY RESOLUTION, supra note 1, at 2.
36. Id.
37. Although an unintended discriminatory impact may not always be
constitutionally objectionable, Washington v. Davis, 426 U.S. 229,
239-242 (1976), it is inconsistent with best practices for drug
courts.
38. See, e.g., Mary P. Brewster, An Evaluation of the Chester County (PA)
Drug Court Program, J. DRUG ISSUES 177, 194 (2001) (finding
African-American participants were less likely to graduate from a
drug court than Caucasians); Roger E. Hartley & Randy C.
Phillips, Who Graduates from Drug Courts?: Correlates of Client
Success, 26 AM. J. CRIM. JUST. 107, 113 (2001) (finding minorities
significantly less likely to graduate from drug court than nonminorities); KATHARINA L. WIEST ET AL., NPC RESEARCH,
VANDERBURGH COUNTY DAY REPORTING DRUG COURT EVALUATION:
FINAL REPORT 32 (2007), available at http://www.npcresearch.com/
Files/Vanderburgh_Adult_Eval_Final.pdf (finding Caucasians

graduated from drug court 1.74 times more often than nonCaucasians); M. Schiff & C. Terry, Predicting Graduation From
Broward County’s Dedicated Drug Treatment Court, 19 JUST. SYS. J.
291 (1997) (finding minorities significantly less likely to graduate
from drug court than non-minorities); Dale K. Sechrest & David
Shicor, Determinants of Graduation from a Day Treatment Drug
Court in California: A Preliminary Study, 31 J. DRUG ISSUES 129, 139
(2001) (finding African-American and Hispanic participants less
likely to graduate from drug court than Caucasians); Christine A.
Saum & Matthew L. Hiller, Should Violent Offenders Be Excluded
from Drug Court Participation?, 33 CRIM. J. REV. 291, 300 (2008)
(finding Caucasian participants in drug court less likely to recidivate than non-Caucasians); SHELLI B. ROSSMAN ET AL., NAT’L INST.
JUST., THE MULTI-SITE ADULT DRUG COURT EVALUATION: THE IMPACT
OF DRUG COURTS 75 (2011), available at https://www.ncjrs.gov/
pdffiles1/nij/grants/237112.pdf (finding in a national study of 23
adult drug courts that African-Americans were less likely to show
reductions in recidivism than Caucasians); David M. Stein et al.,
Predicting Success and Failure in Juvenile Drug Treatment Court: A
Meta-Analytic Review, J. SUBSTANCE ABUSE TREATMENT, available at
http://dx.doi.org/10.1016/j.jsat.2012.07.002 (finding nonCaucasian participants had lower graduation rates and higher
recidivism rates than Caucasians in juvenile drug courts).
39. See, e.g., STEVEN BELENKO, NAT’L CTR. ADDICTION & SUBSTANCE
ABUSE, RESEARCH ON DRUG COURTS: A CRITICAL REVIEW, 2001
UPDATE 26 (2001) (reviewing studies reporting lower graduation
rates for minorities in drug courts of approximately 30 to 40 per-

III. MINORITY OUTCOMES IN DRUG COURTS

Numerous studies have reported that a considerably smaller
percentage of minority participants graduated successfully
from drug courts as compared to non-Hispanic Caucasians.38
In several of the studies, the magnitudes of the differences
were quite large—as high as 25 to 40 percentage points.39 This
problem may be particularly pronounced among African-
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American males between the
ages of 18 and 25 years.40 Being
young and male are well-documented risk factors for failure
in drug courts and other correctional rehabilitation programs,41 and it appears that
combining these two risk factors with racial-minority status
may multiply the likelihood of
failure.
These findings are by no
means universal, however, as a
smaller but growing number of
evaluations has found no racial
differences in outcomes or
superior outcomes for minorities as compared to Caucasians, including for those between
the ages of 18 and 25 years.42 Nevertheless, there does appear
to be a plurality trend that African-Americans are less likely to
succeed in many drug courts as compared to their non-racialminority peers.43
A critical unanswered question is whether this disparity is a
function of race per se or whether it might reflect the influence
of other factors that are correlated with race. Many studies
have found that participants’ drug of choice (particularly
cocaine or heroin), employment status, and criminal history
also predicted poorer outcomes in drug courts, and racial
groups differed significantly on these variables.44 For example,

in some communities African-Americans were more likely
than Caucasians to be abusing crack cocaine, and it is possible
that the severely addictive and destructive nature of this particular drug could have been largely responsible for their
poorer outcomes.45 This possibility requires evaluators to statistically take into account the influence of variables that are
correlated with race, such as participants’ drug of choice, and
then determine whether race continues to predict poorer outcomes after such extraneous variables have been factored out.
Only then might it be justified to conclude there are disparate
racial impacts in drug courts.
In fact, a statewide study of ten drug courts in Missouri suggested that other factors might be responsible for some of the
apparent racial differences in outcomes.46 In that study, 55% of
Caucasian participants graduated from the drug courts as compared to only 28% of African-Americans.47 However, greater
proportions of the African-American participants were also
unemployed (56% vs. 39%), unmarried (91% vs. 83%), living
with unrelated individuals (51% vs. 37%), childless (69% vs.
56%), abusing cocaine as their primary drug of choice (45% vs.
13%), experiencing low levels of family support (38% vs.
29%), and of a lower SES.48 After taking these variables into
account, race was no longer predictive of outcomes.49 The top
three factors predicting graduation from the drug courts were
participants’ employment status at entry, SES, and cocaine as
the primary drug of abuse.50
The results of this study suggest that racial disparities in
drug-court-graduation rates (at least in Missouri) might be
explained by broader societal burdens, which may be borne

centage points); WIEST ET AL., supra note 38, at 32 (reporting
lower graduation rate for non-Caucasians of 25 percentage
points); Sechrest & Shicor, supra note 38, at 139 (reporting lower
graduation rates of approximately 37 percentage points for
African-Americans and 27 percentage points for Hispanics).
40. See, e.g., INST. APPLIED RESEARCH, AN ANALYSIS OF THE YOUNG
PERSON TRACK OF THE ST. LOUIS CITY ADULT FELONY DRUG COURT 5
(2003) (finding in a drug court that 94.9% of terminated participants between 17 and 20 years of age were African-American).
41. See generally Douglas B. Marlowe et al., Amenability to Treatment
of Drug Offenders, 67 FED. PROBATION 40 (2003) (reviewing risk
factors for failure in correctional rehabilitation programs, including drug courts).
42. See Gennaro F. Vito & Richard A. Tewksbury, The Impact of
Treatment: The Jefferson County (Kentucky) Drug Court Program, 62
FED. PROBATION 46, 49, Table 1 (1998) (finding approximately
42% graduation rate for African-American drug-court participants, compared to only 22% for Caucasians with a high school
diploma or G.E.D. and 7% for Caucasians without a high school
diploma or G.E.D.); Randal Brown, Drug Court Effectiveness: A
Matched Cohort Study in the Dane County Drug Treatment Court, 50
J. OFFENDER REHAB. 191, 197 (2011) (finding better outcomes in a
drug court for African-Americans and other minorities than for
non-minorities); Andrew Fulkerson, Drug Treatment Court Versus
Probation: An Examination of Comparative Recidivism Rates, 8 SW. J.
CRIM. JUST. 30, 35 (2012) (finding greater reductions in recidivism
in a drug court for African-Americans than Caucasians); Christine
A. Saum et al., Violent Offenders in Drug Court, 31 J. DRUG ISSUES
107, 121 (2001) (finding race had no apparent effect on drug-

court graduation); JULIAN M. SOMERS ET AL., MEDIATORS OF DRUG
TREATMENT COURT OUTCOMES IN VANCOUVER CANADA (Simon Fraser
Univ., 2012) (finding better outcomes for aboriginal natives in a
Canadian drug court).
43. Cf. Michael W. Finigan, Understanding Racial Disparities in Drug
Courts, 6 DRUG CT. REV. 135 (2009).
44. See BELENKO, supra note 39, at 26 (noting lower graduation rates
among minorities might have been influenced by greater likelihood
of abusing cocaine or heroin); Wolf, supra note 18, at 45 (noting
researchers have consistently reported poorer retention and graduation rates in drug courts for participants who were unemployed,
low-wage earners, or less educated, regardless of race or ethnicity);
Hartley & Phillips, supra note 38, at 114, Table 1 (finding participants more likely to graduate from drug court if they entered the
program employed, obtained work during the program, finished
high school, or abused drugs other than cocaine).
45. See generally J. Mitchell Miller & J. Eagle Shutt, Considering the
Need for Empirically Grounded Drug Court Screening Mechanisms,
31 J. DRUG ISSUES 91 (2001) (finding graduation rate for AfricanAmerican drug-court participants not significantly lower than for
Caucasians after accounting for crack cocaine as drug of choice
and lower social stability).
46. Anne Dannerbeck et al., Understanding and Responding to Racial
Differences in Drug Court Outcomes, 5 J. ETHNICITY IN SUBSTANCE
ABUSE 1 (2006).
47. Id. at 11, Table 1.
48. Id. at 11-13, Table 1.
49. Id. at 13.
50. Id. at 14, Table 3.

A critical
unanswered
question is
whether this
disparity is a
function of race
per se or whether
it might reflect
the influence of
other factors that
are correlated
with race.
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disproportionately by minorities, such as lesser educational or
employment opportunities or a greater infiltration of crack
cocaine into some minority communities. If this finding holds
true in further research, it would point to obvious and concrete
measures that drug courts could take to increase minority
completion rates. For example, drug courts might enhance
vocational rehabilitation or educational services in their programs to offset any related disadvantages experienced by
minority participants.51 They might also focus on delivering
interventions that are proven to be successful for treating
cocaine and other stimulant addictions.52

There is ample evidence that racial-and-ethnic-minority citizens may receive lesser-quality treatment in the criminal justice system than non-minorities.53 A commonly cited example
of this phenomenon relates to California’s Proposition 36,54 a
statewide diversion initiative for nonviolent drug-possession
offenders. A several-year study of Proposition 36 by
researchers at UCLA found that Hispanic participants were significantly less likely than Caucasians to be placed in residential treatment for similar patterns of drug abuse, and AfricanAmericans were less likely to receive medically assisted treatment for addiction.55 Not surprisingly, treatment outcomes
were also significantly poorer for these minority groups.56
No quantitative data have yet been reported on whether
such disparities exist within drug courts.57 Qualitative interviews with minority participants in drug courts do not suggest

they perceived themselves as
[I]t is not possible
receiving lesser-quality treatment. To the contrary, in at least to conclude at this
one study, minority participants juncture whether
were seemingly exasperated by treatment services
receiving the same services as
non-minorities and expressed a . . . are or are not
preference for a more individuappropriately
alized and less one-size-fits-all
suited to the
approach.58 Some minority participants in that study were par- needs of minority
participants.
ticularly resentful about being
required to attend 12-step meetings, such as Narcotics Anonymous (NA) or Alcoholics
Anonymous (AA). They reported feeling uncomfortable sharing their feelings in groups and being encouraged to accept the
label of “addict.”59 Instead, they expressed a predilection for
receiving employment and educational services.60
Given how little research has addressed this question, it is
not possible to conclude at this juncture whether treatment
services in drug courts are or are not appropriately suited to
the needs of minority participants.61 Future studies must
empirically examine this issue in a more objective manner.
Until such direct evidence is garnered, drug courts should,
at a minimum, apply generic principles of evidence-based
treatment in their programs. For example, several studies have
demonstrated improved outcomes, including for minority participants, when drug courts administered manualized, structured, cognitive-behavioral curricula.62 Cognitive-behavioral

51. See Laura S. Cresswell & Elizabeth P. Deschenes, Minority and
Non-Minority Perceptions of Drug Court Program Severity and
Effectiveness, 31 J. DRUG ISSUES 259, 277 (2001) (concluding
minority and non-minority participants viewed drug court as similarly helpful, but minorities were more appreciative of employment assistance, and non-minorities were more appreciative of
substance-abuse treatment); John R. Gallagher, Evaluating Drug
Court Effectiveness and Exploring Racial Disparities in Drug
Court Outcomes: A Mixed Methods Study 94 (2012) (unpublished Ph.D. dissertation, Univ. of Texas at Arlington) (on file with
author) (finding African-American drug-court participants preferred employment assistance to treatment interventions); see also
Carl Leukefeld et al., Employment and Work Among Drug Court
Clients: 12-Month Outcomes, 42 SUBSTANCE USE & MISUSE 1109
(2007) (finding better outcomes in drug court when participants
received augmented vocational services).
52. See generally Patricia Marinelli-Casey et al., Drug Court Treatment
for Methamphetamine Dependence: Treatment Response and
Posttreatment Outcomes, 34 J. SUBSTANCE ABUSE TREATMENT 242
(2008) (reporting superior outcomes for drug courts utilizing the
“MATRIX Model” curriculum for stimulant dependence); Richard
A. Rawson et al., A Multi-Site Comparison of Psychosocial
Approaches for the Treatment of Methamphetamine Dependence, 99
ADDICTION 708 (2004) (same).
53. See generally William B. Lawson & Anthony Lawson, Disparities
in Mental Health Diagnosis and Treatment Among African
Americans: Implications for the Correctional Systems, in CRIME, HIV
& HEALTH: INTERSECTIONS OF CRIMINAL JUSTICE AND PUBLIC HEALTH
CONCERNS (B. Sanders et al. eds., forthcoming 2013), available at
DOI: 10.1007/978-90-481-8921-2_4 (reviewing disparities in sub-

stance-abuse and mental-health diagnoses, treatment access, and
treatment outcomes for minorities); Anne Dannerbeck-Janku &
Jiahui Yan, Exploring Patterns of Court-Ordered Mental Health
Services for Juvenile Offenders: Is There Evidence of Systematic
Bias?, 36 CRIM. JUST. & BEHAV. 402, 414 (2009) (finding AfricanAmerican juvenile offenders were less likely than Caucasians to be
referred for needed mental-health services); Steven R. Lopez et al.,
From Documenting to Eliminating Disparities in Mental Health Care
for Latinos, 67 AM. PSYCHOLOGIST 511 (2012); Lonnie R. Snowden,
Health and Mental Health Policies’ Role in Better Understanding and
Closing African American-White American Disparities in Treatment
Access and Quality of Care, 67 AM. PSYCHOLOGIST 524 (2012).
54. California Substance Abuse and Crime Prevention Act of 2000,
CAL. PENAL CODE § 1210 et seq. (West 2000) [hereafter
Proposition 36].
55. UNIV. CAL. LOS ANGELES, INTEGRATED SUBSTANCE ABUSE PROG.,
EVALUATION OF THE SUBSTANCE ABUSE AND CRIME PREVENTION ACT:
FINAL REPORT 5 & 82 (2007) .
56. Id. at 4 (finding treatment completion in Proposition 36 was lower
for Hispanics and African-Americans).
57. See, e.g., Wolf, supra note 18, at 48 (concluding much of what is
known about problem-solving courts and race is “speculative”).
58. Gallagher, supra note 51, at 87, 94.
59. Id. at 90-91.
60. Id. at 88.
61. Cf. Wolf, supra note 18, at 52 (concluding more research needs to
be done on race and drug courts).
62. See generally Cary E. Heck, MRT: Critical Component of a Local
Drug Court Program, 17 COGNITIVE BEHAV. TREATMENT REV. 1, 2
(Correctional Counseling 2008) (finding addition of “Moral
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interventions focus less on the
expression of feelings and
instead take a more active,
problem-solving approach to
managing drug-related problems.63 Several resources are
available to help clinicians in
drug courts select manualized
cognitive-behavioral curricula
that are proven to produce
positive benefits for minority
participants.64
In addition, there is some evidence that providing culturally
proficient or culturally sensitive interventions may improve
results for minorities in drug courts. At least one drug-court
program run by an experienced African-American clinician
and utilizing culturally tailored interventions demonstrated
superior effects for young male African-American participants
over Caucasian participants.65 Efforts are underway to examine
the intervention used in that study—presently named
Habilitation, Empowerment & Accountability Therapy
(H.E.A.T.)—in a controlled experimental study.

[T]here is some
evidence that
providing culturally
proficient or
culturally sensitive
interventions may
improve results for
minorities . . . .

Reconation Therapy” [MRT] to drug-court curriculum produced
better outcomes); Robert A. Kirchner & Ellen Goodman,
Effectiveness and Impact of Thurston County, Washington Drug Court
Program, 16 COGNITIVE BEHAV. TREATMENT REV. 1, 4 (Correctional
Counseling 2007) (finding the completion of each additional step
of MRT in a drug court was associated with an 8% further reduction in recidivism); Marinelli-Casey et al., supra note 52 (reporting superior outcomes for drug courts utilizing the MATRIX
Model for stimulant dependence); Scott W. Henggeler et al.,
Juvenile Drug Court: Enhancing Outcomes by Integrating EvidenceBased Treatments, 74 J. CONSULTING & CLINICAL PSYCHOL. 42, 51
(2006) (finding addition of “Multi-Systemic Therapy” [MST] and
“contingency management” [CM] improved outcomes in a juvenile drug court).
63. See generally AARON T. BECK ET AL., COGNITIVE THERAPY OF
SUBSTANCE ABUSE (1993) (describing cognitive-behavioral treatments for addiction); ALBERT ELLIS ET AL., RATIONAL-EMOTIVE
THERAPY WITH ALCOHOLICS AND SUBSTANCE ABUSERS (1988) (same);
G. ALAN MARLATT & JUDITH R. GORDON, RELAPSE PREVENTION:
MAINTENANCE STRATEGIES IN THE TREATMENT OF ADDICTIVE
BEHAVIORS (1985).
64. The Substance Abuse and Mental Health Services Administration
(SAMHSA) maintains an internet directory of evidence-based
treatments called the National Registry of Evidence-Based
Programs and Practices (NREPP). The NREPP website may be
searched specifically for interventions that have been evaluated
among substantial numbers of racial and ethnic minority participants, at http://www.nrepp.samhsa.gov/AdvancedSearch.aspx
(last visited Nov. 1, 2012). See also Stanley J. Huey & Antonio J.
Polo, Evidence-Based Psychosocial Treatments for Ethnic Minority
Youth, 37 J. CLIN. CHILD & ADOLESCENT PSYCHOL. 262 (2008)
(reviewing effective treatments for Hispanic and Latino/Latina
youths).
65. See Vito & Tewksbury, supra note 42, at 49 (reporting better outcomes for young, male African-American participants when drug
court provided culturally proficient services delivered by an
African-American clinician).
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V.

SANCTIONS AND INCENTIVES FOR MINORITIES IN
DRUG COURTS

A commonly expressed concern about drug courts is that
minority participants might be sanctioned more severely than
non-minorities for comparable infractions. Anecdotal observations have typically been proffered to support this allegation,66
and minority participants in at least one focus group did report
feeling more likely than other participants to be ridiculed or
laughed at during court sessions in response to violations.67
No empirical study, however, has borne out the assertion. To
the contrary, what little research has been conducted suggests
that problem-solving courts, including drug courts, appear to
administer sanctions in a racially and ethnically even-handed
manner.68 Considerably more research is required, however, to
study this important issue in a more systematic manner and in
a representative range of drug-court programs.
A related concern is that minority participants might be
sentenced more harshly than non-minorities for failing out of
drug court.69 This is a particularly important matter because,
as previously discussed, minorities may be more likely to be
terminated from drug court than non-minorities.70 Although
this issue is far from settled,71 there is some evidence that participants who were terminated from a few drug courts did

66. See, e.g., NACDL REPORT, supra note 17, at 43 (citing personal
observation of one lawyer that Caucasian participants are given
more chances before a violation than minorities in a drug court).
67. Gallagher, supra note 51, at 93 (reporting the perceptions of three
African-American drug-court participants that the judge, staff,
and/or observers laughed at them or were disrespectful during
sanction hearings).
68. See generally Wendy P. Guastaferro & Leah E. Daigle, Linking
Noncompliant Behaviors and Programmatic Responses: The Use of
Graduated Sanctions in a Felony-Level Drug Court, 42 J. DRUG
ISSUES 396, 410, Table 5 (2012) (finding race was not related to the
imposition of sanctions in a felony drug court); Patricia L. Arabia
et al., Sanctioning Practices in an Adult Felony Drug Court, 6 DRUG
CT. REV. 1 (2008) (finding a felony drug court serving 62%
African-American participants and 25% Hispanic participants
administered sanctions in a gradually escalating manner consistent with effective principles of behavior modification); Lisa
Callahan et al., A Multi-Site Study of the Use of Sanctions and
Incentives in Mental Health Courts, LAW & HUMAN BEHAV. 1, 4
(2012), available at DOI: 10.1037/h0093989 (finding no demographic characteristics, including race, predicted the imposition
of jail sanctions in several mental-health courts); M. SOMJEN
FRAZER, CTR. FOR CT. INNOVATION, THE IMPACT OF THE COMMUNITY
COURT MODEL ON DEFENDANT PERCEPTIONS OF FAIRNESS 18, Table 3
(2006) (finding race was not related to participants’ perceptions of
procedural fairness when sanctions and incentives were imposed
in a community court).
69. See, e.g., O’Hear, supra note 17, at 480 (suggesting failure in drug
court may lead to harsher sentences for minorities than not participating in drug court); NACDL REPORT, supra note 17, at 43
(same); JUST. POL’Y INST., supra note 17, at 24.
70. See supra notes 38-43 and accompanying text for a discussion of
graduation rates among minorities and non-minorities in drug
courts.
71. See JUST. POL’Y INST., supra note 17, at 24 (acknowledging very few
studies have compared dispositions for participants who failed
drug court to those traditionally adjudicated).

appear to receive relatively harsher sentences than traditionally
adjudicated defendants charged with comparable offenses.72
There is no evidence, however, to suggest whether this practice
differentially impacts minorities as compared to non-minorities. Moreover, no information is available on whether there
might have been a rational basis for the judges in those cases
to augment the sentences as they did.
How and when augmented sentences are imposed in drug
courts is among the most important questions that need to be
carefully studied by researchers. Currently, there appears to be
no clear consensus about whether, or under what circumstances, it is appropriate to increase a presumptive sentence for
one who fails a diversion opportunity, such as drug court; however, participants must be informed of the possibility of an augmented sentence when they execute waivers to enter the program.73
Ideally, defense attorneys and potential participants should
be armed with more than just the mere knowledge that an augmented sentence could be imposed. Where possible, they
should be armed with data about how likely this is to occur
and what factors the judge is apt to take into account when
rendering such a decision. Researchers need to enlighten the
drug-court field about how these important matters are determined and, most important, whether these decisions may
unfairly or disproportionately impact racial-or-ethnic-minority
participants.
VI. CONCLUSIONS

Much of the discourse surrounding racial- and ethnicminority experiences in drug courts has shed more heat on the
matter than light. Anecdotal impressions have been miscast as
scientific data, simple correlations have been misinterpreted as
proof of causality, and simplistic, even nihilistic solutions have
been proffered to address complex problems of crime and drug
policy.
Here is what is known:
• African-Americans appear to be underrepresented in adult
drug courts by an average of a few percentage points.
• African-American participants, and to a lesser extent
Hispanic and Latino/Latina participants, are considerably
less likely than Caucasians to graduate from a plurality of
drug courts, but not all drug courts. This difference does not
appear to be a function of race or ethnicity per se, but rather
a function of other socio-demographic characteristics which
may be correlated with race or ethnicity.
• Evidence suggests graduation rates for African-American
and Hispanic participants may be substantially increased by:
• providing vocational services and assistance;
• administering structured, cognitive-behavioral treatment
curricula;

72. See Josh Bowers, Contraindicated Drug Courts, 55 UCLA L. REV.
783, 792 (2008) (concluding sentences for participants who were
terminated from drug courts in New York were two to five times
longer than for conventionally adjudicated defendants).
73. See generally William G. Meyer, Constitutional and Legal Issues in
Drug Courts, in NAT’L DRUG CT. INST., THE DRUG COURT JUDICIAL
BENCHBOOK 159, 164 (Douglas B. Marlowe & William G. Meyer

• administering treatments that are focused on the prevalent drugs of choice in minority communities (e.g.,
cocaine and heroin);
• better preparing minority participants for what to expect
before referring them to 12-step meetings; and
• administering culturally tailored interventions for young
African-American males.
• Empirical evidence does not support the assertion that
minority participants receive different sanctions for comparable infractions in drug courts; however, insufficient
research has addressed this question.
• No valid research has investigated whether minority participants are sentenced more harshly than non-minorities for
failing drug court.
Clearly, the drug-court field is left with more questions than
answers. More research is needed to determine what services
minority participants typically receive in drug courts, how to
enhance minority outcomes in drug courts, and what consequences typically ensue from program failure. Moreover, little
is known about the impacts of drug courts on minority groups
other than African-Americans and Hispanics. Researchers need
to make extra efforts to recruit a diverse range of citizens into
their studies and validly assess disparate impacts across the full
spectrum of racial and ethnic subgroups that are enrolled in
drug-court programs or charged with drug-related offenses.
Drug courts are, first and foremost, courts, and the most
fundamental principles of due process and equal protection
continue to apply to their operations.74 Drug courts came into
being to solve some of our most dire social ills, and it would be
a tragedy if programs designed to help people exacerbated
their problems. Moreover, drug courts were created to correct
certain social injustices emanating from the War on Drugs, and
they must not turn a blind eye to the faintest possibility that
they might be exacerbating some of those self-same injustices.
It is incumbent upon drug courts to take a fearless inventory
of their actions, admit their shortcomings where applicable,
and continue striving to perform their vital work ever more
effectively and humanely.75
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eds., 2011) (noting waiver of trial rights in drug courts must be
knowing, voluntary, and intelligent).
74. See, e.g., id. at 163 (noting drug courts must safeguard the dueprocess rights of participants).
75. Some readers might recognize these principles as stemming from
the precepts of AA and NA. See ALCOHOLICS ANONYMOUS WORLD
SERVICES, TWELVE STEPS AND TWELVE TRADITIONS 6-8 (1981).
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